A股收評:放量大升!滬指升2%,深成指、創業板指升超3.3%,牛市旗手爆發
昨日重磅會議指提振投資者信心,提升資本市場內在穩定性。A股主要指數今日低開高走,滬指收復2900點;截至收盤,滬指升2.06%報2938點,深證成指升3.37%,創業板指升3.51%。超5000股上升,全天成交9033億元,較昨日放量3038億元。盤面上,中金、銀河再傳合併,證券板塊大升,首創證券、太平洋證券等多股升停;醫療服務板塊衝高,金域醫學、通策醫療等多股升停;《優化創新藥臨牀試驗審評審批試點工作方案》獲通過,創新藥板塊走高,昭衍新藥升停;AI芯片、短劇概念及機器人執行器等板塊升幅居前;鐵路公路、銀行及ST板塊等小幅上升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.